Literature DB >> 25918145

Meropenem and chromacef intermediates observed in IMP-25 metallo-β-lactamase-catalyzed hydrolysis.

Peter Oelschlaeger1, Mahesh Aitha2, Hao Yang2, Joon S Kang3, Antonia L Zhang4, Eleanor M Liu4, John D Buynak5, Michael W Crowder2.   

Abstract

Metallo-β-lactamases inactivate most β-lactam antibacterials, and much attention has been paid to their catalytic mechanism. One issue of controversy has been whether β-lactam hydrolysis generally proceeds through an anionic intermediate bound to the active-site Zn(II) ions or not. The formation of an intermediate has not been shown conclusively in imipenemase (IMP) enzymes to date. Here, we provide evidence that intermediates are formed during the hydrolysis of meropenem and chromacef catalyzed by the variant IMP-25 and, to a lesser degree, IMP-1.
Copyright © 2015, American Society for Microbiology. All Rights Reserved.

Entities:  

Mesh:

Substances:

Year:  2015        PMID: 25918145      PMCID: PMC4468739          DOI: 10.1128/AAC.04409-14

Source DB:  PubMed          Journal:  Antimicrob Agents Chemother        ISSN: 0066-4804            Impact factor:   5.191


  19 in total

1.  Plasmid-encoded metallo-beta-lactamase (IMP-6) conferring resistance to carbapenems, especially meropenem.

Authors:  H Yano; A Kuga; R Okamoto; H Kitasato; T Kobayashi; M Inoue
Journal:  Antimicrob Agents Chemother       Date:  2001-05       Impact factor: 5.191

2.  Analysis of the importance of the metallo-beta-lactamase active site loop in substrate binding and catalysis.

Authors:  Catherine Moali; Christine Anne; Josette Lamotte-Brasseur; Sylvie Groslambert; Bart Devreese; Jozef Van Beeumen; Moreno Galleni; Jean Marie Frère
Journal:  Chem Biol       Date:  2003-04

3.  Update of the standard numbering scheme for class B beta-lactamases.

Authors:  Gianpiero Garau; Isabel García-Sáez; Carine Bebrone; Christine Anne; Paola Mercuri; Moreno Galleni; Jean-Marie Frère; Otto Dideberg
Journal:  Antimicrob Agents Chemother       Date:  2004-07       Impact factor: 5.191

4.  High frequency of IMP-6 among clinical isolates of metallo-β-lactamase-producing Escherichia coli in Japan.

Authors:  Hisakazu Yano; Miho Ogawa; Shiro Endo; Risako Kakuta; Hajime Kanamori; Shinya Inomata; Noriomi Ishibashi; Tetsuji Aoyagi; Masumitsu Hatta; Yoshiaki Gu; Mitsuhiro Yamada; Koichi Tokuda; Hiroyuki Kunishima; Miho Kitagawa; Yoichi Hirakata; Mitsuo Kaku
Journal:  Antimicrob Agents Chemother       Date:  2012-06-04       Impact factor: 5.191

5.  Probing the role of Asp-120(81) of metallo-beta-lactamase (IMP-1) by site-directed mutagenesis, kinetic studies, and X-ray crystallography.

Authors:  Yoshihiro Yamaguchi; Takahiro Kuroki; Hisami Yasuzawa; Toshihiro Higashi; Wanchun Jin; Akiko Kawanami; Yuriko Yamagata; Yoshichika Arakawa; Masafumi Goto; Hiromasa Kurosaki
Journal:  J Biol Chem       Date:  2005-03-23       Impact factor: 5.157

6.  Mimicking natural evolution in metallo-beta-lactamases through second-shell ligand mutations.

Authors:  Pablo E Tomatis; Rodolfo M Rasia; Lorenzo Segovia; Alejandro J Vila
Journal:  Proc Natl Acad Sci U S A       Date:  2005-09-19       Impact factor: 11.205

7.  Familial mutations and zinc stoichiometry determine the rate-limiting step of nitrocefin hydrolysis by metallo-beta-lactamase from Bacteroides fragilis.

Authors:  W Fast; Z Wang; S J Benkovic
Journal:  Biochemistry       Date:  2001-02-13       Impact factor: 3.162

Review 8.  Metallo-β-lactamases: a last frontier for β-lactams?

Authors:  Giuseppe Cornaglia; Helen Giamarellou; Gian Maria Rossolini
Journal:  Lancet Infect Dis       Date:  2011-05       Impact factor: 25.071

9.  Evolution of Metallo-β-lactamases: Trends Revealed by Natural Diversity and in vitro Evolution.

Authors:  María-Rocío Meini; Leticia I Llarrull; Alejandro J Vila
Journal:  Antibiotics (Basel)       Date:  2014-07-01

10.  Biochemical, mechanistic, and spectroscopic characterization of metallo-β-lactamase VIM-2.

Authors:  Mahesh Aitha; Amy R Marts; Alex Bergstrom; Abraham Jon Møller; Lindsay Moritz; Lucien Turner; Jay C Nix; Robert A Bonomo; Richard C Page; David L Tierney; Michael W Crowder
Journal:  Biochemistry       Date:  2014-11-13       Impact factor: 3.162

View more
  5 in total

1.  Carbapenem Use Is Driving the Evolution of Imipenemase 1 Variants.

Authors:  Zishuo Cheng; Christopher R Bethel; Pei W Thomas; Ben A Shurina; John-Paul Alao; Caitlyn A Thomas; Kundi Yang; Steven H Marshall; Huan Zhang; Aidan M Sturgill; Andrea N Kravats; Richard C Page; Walter Fast; Robert A Bonomo; Michael W Crowder
Journal:  Antimicrob Agents Chemother       Date:  2021-03-18       Impact factor: 5.191

2.  Structural insights into the design of reversible fluorescent probes for metallo-β-lactamases NDM-1, VIM-2, and IMP-1.

Authors:  Sky Price; Radhika Mehta; Dominique Tan; Abigail Hinojosa; Pei W Thomas; Tawanda Cummings; Walter Fast; Emily L Que
Journal:  J Inorg Biochem       Date:  2022-05-20       Impact factor: 4.336

3.  A general reaction mechanism for carbapenem hydrolysis by mononuclear and binuclear metallo-β-lactamases.

Authors:  María-Natalia Lisa; Antonela R Palacios; Mahesh Aitha; Mariano M González; Diego M Moreno; Michael W Crowder; Robert A Bonomo; James Spencer; David L Tierney; Leticia I Llarrull; Alejandro J Vila
Journal:  Nat Commun       Date:  2017-09-14       Impact factor: 14.919

Review 4.  Metallo-β-Lactamase Inhibitors Inspired on Snapshots from the Catalytic Mechanism.

Authors:  Antonella R Palacios; María-Agustina Rossi; Graciela S Mahler; Alejandro J Vila
Journal:  Biomolecules       Date:  2020-06-03

5.  Use of ferrous iron by metallo-β-lactamases.

Authors:  Samuel T Cahill; Hanna Tarhonskaya; Anna M Rydzik; Emily Flashman; Michael A McDonough; Christopher J Schofield; Jürgen Brem
Journal:  J Inorg Biochem       Date:  2016-07-26       Impact factor: 4.155

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.